CuteraCUTR
CUTR
About: Cutera Inc is a medical device company that specializes in designing, developing, manufacturing, marketing, and servicing laser and other energy-based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States segment. Its products enable medical practitioners to perform safe procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions.
Employees: 430
0
Funds holding %
of 7,363 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
200% more call options, than puts
Call options by funds: $3K | Put options by funds: $1K
4.05% less ownership
Funds ownership: 33.24% [Q3] → 29.19% (-4.05%) [Q4]
7% less funds holding
Funds holding: 56 [Q3] → 52 (-4) [Q4]
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
58% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 19
61% less capital invested
Capital invested by funds: $5.27M [Q3] → $2.08M (-$3.19M) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for CUTR.
Financial journalist opinion
Based on 3 articles about CUTR published over the past 30 days
Neutral
Business Wire
1 day ago
Cutera Announces Voluntarily Delisting from Nasdaq
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (“Cutera” or the “Company”) (Nasdaq: CUTR) today announced that it has formally notified The Nasdaq Stock Market LLC (“Nasdaq”) of its intent to voluntarily delist its common stock from the Nasdaq Global Select Market. Cutera expects to file a Form 25 with the Securities and Exchange Commission (the "SEC") relating to the voluntary delisting of its common stock on or about March 20, 2025. The Company expects the delisting of the common stock to be.
Neutral
Business Wire
6 days ago
Cutera Takes Steps to Strengthen Financial Foundation and Position the Company for Long-Term Success
BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC., (“Cutera” or “the Company”), a leading provider of aesthetic and dermatology solutions, today announced that it is initiating a restructuring transaction with the support of a group of existing lenders, representing approximately 74% of the Company's notes, to strengthen its balance sheet and position Cutera for long-term success. Through the transaction, Cutera will reduce its debt by nearly $400 million, or over 90%, and raise $65 million in ne.
Neutral
GlobeNewsWire
4 weeks ago
Dermatology Devices Market Report 2025, with Key Player Profiles for Cutera, Lumenis, Alma Lasers, Solta Medical and Aesthetic Group
Dublin, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The "Dermatology Devices Market Report 2025" has been added to ResearchAndMarkets.com's offering. The global dermatology devices market is experiencing a significant surge, with projections estimating a growth from $15.93 billion in 2024 to an impressive $18.38 billion in 2025. This notable increase at a compound annual growth rate (CAGR) of 15.4% is partly driven by heightened awareness of skin health and a rise in dermatological condition prevalence. Additionally, an aging population, the escalating demand for aesthetic and cosmetic procedures, and advancements in skin cancer diagnostics are contributing factors to this upward trend.
Neutral
GlobeNewsWire
1 month ago
Aesthetic Medicine Market Expected To Reach USD 170.41 Billion by 2032, Growing at CAGR 8.40% | Allergan, Alma Lasers, Cutera, Cynosure
Aesthetic Medicine improves physical appearance through non-invasive to minimally invasive techniques, provided by physicians in all specialties, usually with local or no anaesthesia. Aesthetic Medicine improves physical appearance through non-invasive to minimally invasive techniques, provided by physicians in all specialties, usually with local or no anaesthesia.
Neutral
Business Wire
3 months ago
Cutera® Announces Partnership with the Adaptive Training Foundation
BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announces their partnership with the Adaptive Training Foundation (ATF), a non-profit organization that provides access and inclusion to individuals living with physical or traumatic impairments empowering them through exercise and community. The Cutera team, with the support of Edward Alvarez, DDS, C.Ac, owner of Madison Avenue Face and Body, has provided ATF participants.
Neutral
Seeking Alpha
4 months ago
Cutera, Inc. (CUTR) Q3 2024 Earnings Call Transcript
Cutera, Inc. (NASDAQ:CUTR ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Shelby Eckerman - Vice President of Finance Taylor Harris - Chief Executive Officer Stuart Drummond - Interim-Chief Financial Officer Conference Call Participants Jonathan Block - Stifel Anthony Vendetti - Maxim Group Macauley Kilbane - William Blair Operator Thank you for standing by. This is the conference operator.
Negative
Zacks Investment Research
4 months ago
Cutera (CUTR) Reports Q3 Loss, Misses Revenue Estimates
Cutera (CUTR) came out with a quarterly loss of $1.85 per share versus the Zacks Consensus Estimate of a loss of $0.96. This compares to loss of $1.61 per share a year ago.
Neutral
Business Wire
4 months ago
Cutera® Announces Third Quarter 2024 Financial Results
BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today reported financial results for the third quarter ended September 30, 2024. Consolidated revenue for the third quarter of 2024 of $32.5 million Cash, cash equivalents, and restricted cash of $59.0 million AviClear growth of 16% vs prior year period driven by international capital system sales Global core capital growth of 7% on a sequential quarterly basis Full-year gu.
Neutral
Business Wire
5 months ago
Cutera® to Announce Third Quarter Results on November 7, 2024
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced today that it will report financial results for the third quarter ended September 30, 2024, after the market closes on Thursday, November 7, 2024. The Company's management will host a conference call to discuss these results and related matters at 1:30 p.m. PT (4:30 p.m ET) that same day. Participants can register for the conference call at the following registrat.
Negative
GuruFocus
5 months ago
Cutera (CUTR) Stock Drops 5.14% Amid Financial Challenges
Cutera Inc. (CUTR, Financial) experienced a significant stock price decline of 5.14%, bringing its price to $0.751 per share. The trading volume reached 26,733 shares, with a turnover rate of 0.13% and a price fluctuation of 5.03%.
Charts implemented using Lightweight Charts™